AI in Biomedical R&D and Healthcare: Breakthrough, Band-Aid, or Existential Risk?

Artificial intelligence is reshaping the biomedical and health ecosystem, from drug discovery and translational research to public health analytics and clinical care delivery. Its expanding role across healthcare and the life sciences brings a juxtaposition of transformative potential and societal risk that remain closely intertwined. In this talk, I will explore case studies that highlight radical breakthroughs and emerging risks to examine how we might maximize the benefits of AI while mitigating the potential for harm – thereby unlocking a future in which AI consistently improves health.